
ChZPSN-Profnastil PAO
MOEX:PRFN

Intrinsic Value
The intrinsic value of one
PRFN
stock under the Base Case scenario is
9.42
RUB.
Compared to the current market price of 3.846 RUB,
ChZPSN-Profnastil PAO
is
Undervalued by 59%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
ChZPSN-Profnastil PAO
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
ChZPSN-Profnastil PAO
Balance Sheet Decomposition
ChZPSN-Profnastil PAO
Current Assets | 5B |
Cash & Short-Term Investments | 1.3B |
Receivables | 392.6m |
Other Current Assets | 3.2B |
Non-Current Assets | 2.1B |
Long-Term Investments | 101.7m |
PP&E | 2B |
Intangibles | 42k |
Free Cash Flow Analysis
ChZPSN-Profnastil PAO
RUB | |
Free Cash Flow | RUB |
Earnings Waterfall
ChZPSN-Profnastil PAO
Revenue
|
16.7B
RUB
|
Cost of Revenue
|
-15.8B
RUB
|
Gross Profit
|
985.3m
RUB
|
Operating Expenses
|
-475.2m
RUB
|
Operating Income
|
510.1m
RUB
|
Other Expenses
|
-88.3m
RUB
|
Net Income
|
421.8m
RUB
|
PRFN Profitability Score
Profitability Due Diligence
ChZPSN-Profnastil PAO's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Score
ChZPSN-Profnastil PAO's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
PRFN Solvency Score
Solvency Due Diligence
ChZPSN-Profnastil PAO's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
ChZPSN-Profnastil PAO's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PRFN Price Targets Summary
ChZPSN-Profnastil PAO
Dividends
Current shareholder yield for PRFN is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PRFN
stock under the Base Case scenario is
9.42
RUB.
Compared to the current market price of 3.846 RUB,
ChZPSN-Profnastil PAO
is
Undervalued by 59%.